International pandemic influenza preparedness plans lack prioritizationOctober 17, 2006Countries vary in determining who should receive vaccines and antivirals One-third of countries engaged in pandemic influenza planning have not prioritized who should get vaccinations and antiviral medications, according to researchers from the Johns Hopkins Bloomberg School of Public Health and the Ben-Gurion University of the Negev, Israel. The study authors performed the largest pandemic-plan review to date, a targeted review of 45 national pandemic influenza plans from developed and developing countries. The study is published in the October 2006 issue of the journal PLoS Medicine. "Because of costs and the time delay of manufacturing strain-specific vaccines, critical medical resources are likely to be scarce in a pandemic and will require rationing. However, we learned that individual countries have not consistently prioritized population groups for vaccines and antivirals. No countries prioritized population groups to receive ventilators, face masks and other critical resources," said Lori Uscher-Pines, lead author of the study and a doctoral candidate in the Bloomberg School of Public Health's Department of Health Policy and Management. The study authors included 45 national pandemic influenza plans in their study-19 from developed and 26 from developing nations. In total, the plans would affect 3.8 billion individuals, or two-thirds of the world population. The study found that 28 countries prioritized individual population groups to receive vaccines in a pandemic; 22 prioritized groups to receive antiviral medications during a pandemic. The failure to prioritize antivirals is an unexpected finding since they may be the first-and perhaps the only-pharmaceutical intervention available to many countries in a pandemic, the authors explain in the study. Of the 28 nations that prioritized medical resources, health care workers were most frequently ranked at the top of vaccine and antiviral priority lists. After that, countries differed greatly on who should receive top priority-high-risk individuals, such as the elderly and children, or essential service workers, such as communications/telecommunications workers, fire fighters, key government decision makers and energy/power supply workers. The authors also learned that some countries made children a top priority, despite mixed epidemiological support of this practice and a previous World Health Organization recommendation against it. None of these countries cited sociocultural values in reference to this prioritization decision. "Prioritization can play a significant role in international preparedness against pandemic influenza. In the absence of explicit WHO guidelines, nations should be encouraged and supported in priority-setting based on individualized pandemic-impact estimates, and should be guided in balancing evidence and ethical considerations," said Ran D. Balicer, MD, MPH, of the Ben-Gurion University, senior co-author of the study. Johns Hopkins University Bloomberg School of Public Health |
|||||||||||||||||||||
| Related Influenza Current Events and Influenza News Articles Amid the flu epidemic, don't forget RSV in young children Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Preventing H1N1 spread to health care workers: Dilemma, debate and confusion A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. New culprit for viral infections among elderly -- an overactive immune response Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. New research helps explain why bird flu has not caused a pandemic Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE. Mechanical ventilation for patients with lung damage don't always work as planned As more Canadians are diagnosed with H1N1 influenza infection, some will be admitted to hospital. The most severely affected may be treated in the intensive care unit (ICU) and placed on a mechanical ventilator to help them breathe while they recover from the infection. Researchers mobilizing global resources to test new treatments for severe H1N1 infection An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Worksite wellness programs may reduce employee absenteeism Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. More Influenza Current Events and Influenza News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||